dihydroxyphenylalanine has been researched along with 3-amino-4-(2-dimethylaminomethylphenylsulfanyl)benzonitrile in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, DJ; Chaudhuri, KR; Metta, V; Pavese, N; Ramlackhansingh, A; Simpson, BS | 1 |
1 other study(ies) available for dihydroxyphenylalanine and 3-amino-4-(2-dimethylaminomethylphenylsulfanyl)benzonitrile
| Article | Year |
|---|---|
[¹⁸F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [¹⁸F]FDOPA and [¹¹C]DASB PET study in Parkinson's disease.
Topics: Aged; Aniline Compounds; Biological Availability; Dihydroxyphenylalanine; Female; Humans; Male; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Raphe Nuclei; Serotonin Plasma Membrane Transport Proteins; Sulfides; Tissue Distribution | 2012 |